Last update 13 Dec 2024
JMT-601
Last update 13 Dec 2024
Overview
Basic Info
Drug Type Antibody fusion proteins |
Synonyms CPO107, JMT-601 |
Target |
Mechanism CD20 inhibitors(B-lymphocyte antigen CD20 inhibitors), SIRPα inhibitors(Signal-regulatory protein alpha inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
RegulationFast Track (US), Orphan Drug (US) |
Login to view timeline
Related
4
Clinical Trials associated with JMT-601评价JMT601联合不同化疗方案治疗CD20阳性弥漫性大B细胞淋巴瘤参与者的有效性和安全性的多中心、Ⅱ期临床研究
[Translation] A multicenter, phase II clinical study to evaluate the efficacy and safety of JMT601 combined with different chemotherapy regimens in the treatment of participants with CD20-positive diffuse large B-cell lymphoma
试验专业题目 评价JMT601 治疗复发/难治性CD20 阳性B 细胞非霍奇金淋巴瘤的Ⅰ 期临床研究
[Translation] A Phase I clinical study evaluating JMT601 for the treatment of relapsed/refractory CD20-positive B-cell non-Hodgkin's lymphoma
Phase 1/2, Multicenter, First-In-Human, Dose Escalation and Dose Expansion Study of CPO107 Administered Intravenously to Patients With Advanced CD20-positive Non-Hodgkins Lymphoma
100 Clinical Results associated with JMT-601
Login to view more data
100 Translational Medicine associated with JMT-601
Login to view more data
100 Patents (Medical) associated with JMT-601
Login to view more data
100 Deals associated with JMT-601
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| CD20 positive Diffuse Large B-Cell Lymphoma | Phase 2 | CN | 20 Nov 2024 | |
| CD20 positive Non-Hodgkin Lymphoma | Phase 2 | US | 13 Dec 2021 | |
| Non-Hodgkin Lymphoma | Phase 2 | US | 04 Jan 2021 | |
| B-cell lymphoma recurrent | Phase 1 | CN | 17 Dec 2021 | |
| B-cell lymphoma refractory | Phase 1 | CN | 17 Dec 2021 | |
| CD20 Positive B-Cell Non-Hodgkin Lymphoma | Phase 1 | CN | 12 Oct 2021 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free